These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Neuroprotection after spinal cord injury: state of the science. Segatore M; Way C SCI Nurs; 1997 Mar; 14(1):8-18. PubMed ID: 9165951 [TBL] [Abstract][Full Text] [Related]
5. Update on the treatment of spinal cord injury. Baptiste DC; Fehlings MG Prog Brain Res; 2007; 161():217-33. PubMed ID: 17618980 [TBL] [Abstract][Full Text] [Related]
6. New pharmacologic approaches to acute spinal cord injury. Rhoney DH; Luer MS; Hughes M; Hatton J Pharmacotherapy; 1996; 16(3):382-92. PubMed ID: 8726596 [TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effect of Scutellaria baicalensis on spinal cord injury in rats. Yune TY; Lee JY; Cui CM; Kim HC; Oh TH J Neurochem; 2009 Aug; 110(4):1276-87. PubMed ID: 19519665 [TBL] [Abstract][Full Text] [Related]
8. New drugs for improving injury outcome in spinal cord injuries. Werner PC West J Med; 1997 Apr; 166(4):271-2. PubMed ID: 9168687 [No Abstract] [Full Text] [Related]
9. Blockade of sodium channels by phenytoin protects ultrastructure and attenuates lipid peroxidation in experimental spinal cord injury. Kaptanoglu E; Solaroglu I; Surucu HS; Akbiyik F; Beskonakli E Acta Neurochir (Wien); 2005 Apr; 147(4):405-12; discussion 412. PubMed ID: 15696267 [TBL] [Abstract][Full Text] [Related]
10. Recombinant human erythropoietin decreases myeloperoxidase and caspase-3 activity and improves early functional results after spinal cord injury in rats. Okutan O; Solaroglu I; Beskonakli E; Taskin Y J Clin Neurosci; 2007 Apr; 14(4):364-8. PubMed ID: 17236773 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological management of spinal cord injury: current status of drugs designed to augment functional recovery of the injured human spinal cord. Greene KA; Marciano FF; Sonntag VK J Spinal Disord; 1996 Oct; 9(5):355-66. PubMed ID: 8938603 [TBL] [Abstract][Full Text] [Related]